Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$56.23 - $71.17 $157,275 - $199,062
-2,797 Reduced 13.18%
18,417 $1.07 Million
Q1 2023

May 15, 2023

BUY
$53.43 - $68.12 $792,740 - $1.01 Million
14,837 Added 232.66%
21,214 $1.31 Million
Q4 2022

Feb 14, 2023

SELL
$61.23 - $83.62 $739,780 - $1.01 Million
-12,082 Reduced 65.45%
6,377 $405,000
Q3 2022

Nov 14, 2022

BUY
$65.58 - $84.69 $1.21 Million - $1.56 Million
18,459 New
18,459 $1.34 Million
Q3 2021

Nov 15, 2021

SELL
$71.29 - $95.99 $427,526 - $575,652
-5,997 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$79.62 - $114.85 $412,750 - $595,382
-5,184 Reduced 46.36%
5,997 $559,000
Q1 2021

May 14, 2021

SELL
$77.91 - $125.92 $923,545 - $1.49 Million
-11,854 Reduced 51.46%
11,181 $1.2 Million
Q4 2020

Feb 16, 2021

BUY
$60.0 - $87.29 $1.38 Million - $2.01 Million
23,035 New
23,035 $2.01 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.